Discover
TELO
Telomir Pharmaceuticals, Inc.
1.30
2 x 0.92
2 x 1.63
bid
ask
+
0.02
1.56%
2 @ 04:00 PM
1.30 +0.00 (0.00%)
| Ytd | -2.26% | |
| 1y | 2.36% |
1.25
day range
1.35
1.05
52 week range
3.10
| Open | 1.28 | Prev Close | 1.28 | Low | 1.25 | High | 1.35 | Mkt Cap | 89.41M |
| Vol | 125.71K | Avg Vol | 153.33K | EPS | -0.29 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 5.77 | Inst. Own | 6.92% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.30 | 200-d Avg | 1.35 | 1yr Est | 12.15 |
TELO News
benzinga.com
Telomir Pharmaceuticals Publishes Peer-Reviewed Preclinical Data In Biomedicine & Pharmacotherapy Ti
Insulin Resistance Was Normalized Following 14 Days of Treatment, Supporting Restoration of Glucose
benzinga.com
Telomir Pharmaceuticals Appoints Andriy Mushak As Fractional CFO Following Departure Of CFO Alan Wei
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;